Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Rachel Mary Thornley has worked on the following 14 EPO patent applications which have been published in the last five years:

EP12702153

RSV IMMUNIZATION REGIMEN

IPC classification:
A61K 39/155, A61P 31/14
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13734111

NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES

IPC classification:
A61K 39/155, C07K 16/44, C12N 15/861, C12N 15/863
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13752923

METHOD FOR ELICITING IN INFANTS AN IMMUNE RESPONSE AGAINST RSV

IPC classification:
A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13774498

METHOD FOR ELICITING IN INFANTS AN IMMUNE RESPONSE AGAINST RSV AND B. PERTUSSIS

IPC classification:
A61K 39/02, A61K 39/10, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13774463

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

IPC classification:
A61K 39/00, A61K 39/102, A61K 39/29
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13783578

STAPHYLOCOCCUS AUREUS SDRE CNAB DOMAIN AND ITS USE FOR VACCINATION

IPC classification:
A61K 39/085, C07K 14/315, C12N 15/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13792915

RSV F PREFUSION TRIMERS

IPC classification:
A61K 39/12, C07K 14/005
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14750176

COMBINATION IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/10, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14766824

A CHEMICALLY DEFINED MEDIUM FOR THE INDUSTRIAL SCALE CULTURE OF A SPECIES OF BORDETELLA

IPC classification:
C12N 1/20
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
The patent has been granted
EP14819085

PROCESS FOR IDENTIFYING CULTURE CONDITIONS FOR A CELL OR ORGANISM

IPC classification:
C12N 1/20, G06F 19/12
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16180926

RECOMBINANT RSV ANTIGENS

IPC classification:
A61K 9/107, A61K 9/127, A61K 39/00, A61K 39/12, A61K 39/155, A61K 39/295, A61P 31/14, A61P 37/04, C07K 14/005, C07K 14/135, C07K 19/00, C12N 15/45, C12N 15/62
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15713531

NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE

IPC classification:
A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16188862

IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NEUROLOGIC DISORDERS

IPC classification:
A61K 31/00, A61K 31/7008, A61K 31/7056, A61K 39/00, A61K 39/39, A61K 39/395, A61P 25/28
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15733370

IMMUNOGENIC COMBINATIONS

IPC classification:
A61K 39/235, C07K 14/135
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Rachel Mary Thornley, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature